Pim Kinase Inhibitors for the Treatment of Cancer and Possibly More

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTPim Kinase Inhibitors for the Treatment of Cancer and Possibly MoreAhmed F. Abdel-Magid*View Author Information Therachem Research Medilab (India) Pvt. Ltd., Jaipur, India*Address: 1383 Jasper Drive, Ambler, Pennsylvania 19002, United States. Tel: 215-913-7202. E-mail: [email protected]Cite this: ACS Med. Chem. Lett. 2014, 5, 7, 730–731Publication Date (Web):May 1, 2014Publication History Received28 April 2014Published online1 May 2014Published inissue 10 July 2014https://pubs.acs.org/doi/10.1021/ml5001678https://doi.org/10.1021/ml5001678editorialACS PublicationsCopyright © 2014 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views1577Altmetric-Citations12LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (241 KB) Get e-AlertscloseSUBJECTS:Assays,Cancer,Cancer therapy,Peptides and proteins,Post-translational modification Get e-Alerts